Life science blog

Amoy Diagnostics: strengthening precision oncology through strategic partnership

Amoy Diagnostics (AmoyDx) and Almac Diagnostic Services have developed a partnership over the past five years, significantly advancing the field of precision oncology. This collaboration has led to the development and ...
Continue reading

Unlocking Precision: The importance of targeted drug delivery in drug discovery

Targeted delivery is especially vital for reducing off-target effects when developing treatments for complex diseases. Lipid nanoparticles (LNPs) offer a great solution for this.
Continue reading

Difficult biospecimen sourcing: Challenge? Accepted!

Here are some requests from our customers that have kept us on our toes recently, and how we met those requirements.
Continue reading

Long-read sequencing: NGS "method of the year"

Long-read sequencing technologies provide analysis of large and intricate regions of the genome, and recent significant technological advancements in long-read sequencing instruments seem to have reinvigorated interest in this method.
Continue reading

Could the uncharted territory of the gut microbiome be the key to our health?

Dr Alexandre Almeida discussed his research into the diversity of the human gut microbiome at the Festival of Genomics & Biodata 2025. His group focuses on investigating the uncultured portion of the microbiome, which accounts for 60% of all species within it.
Continue reading

Elacestrant for advanced breast cancer: NICE recommendations and ESR1 testing

The National Institute for Health and Care Excellence (NICE) has issued recommendations for the use of Elacestrant in treating oestrogen receptor-positive (ER+), HER2-negative advanced breast cancer with an ESR1 mutation.
Continue reading